BeStock  
Stocks › Biotechnology › IMTX

Immatics IMTX

US equityMarket cap rank #3162Biotechnology
$7.45 −$0.05 (-0.67%)
Pre-market · Oct 8, 7:30 am ET · After hours $7.88 +5.77%
Open$7.44
Prev close$7.50
Day range$7.31 – $7.70
Volume926.2K
Market cap$1.11B
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

Technical signals

Trend readStrong downtrend

0 bullish · 6 bearish of 7 signals

IndicatorValueSignalReading
Price vs 20-day average-11.5%BearishTrading below the 20-day average of $8.41
Price vs 50-day average-16.8%BearishTrading below the 50-day average of $8.96
Price vs 200-day average-24.1%BearishTrading below the 200-day average of $9.82
50-day vs 200-day50d below 200dBearishThe 50-day average is below the 200-day average
RSI (14)30.5BearishMomentum leans negative
MACD (12,26,9)-0.38BearishMACD line is below its signal line
Bollinger band position-2%NeutralBelow the lower band, an extended move

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

Levels & volatility

Moving averages

AverageLevelPrice vs. it
20-day SMA$8.41-11.5%
50-day SMA$8.96-16.8%
200-day SMA$9.82-24.1%

Recent price levels

LevelPrice
20-day high$9.16
20-day low$7.31
60-day high$9.98
60-day low$7.31
Upper Bollinger band$9.33
Lower Bollinger band$7.50

The 50-day average is currently 8.8% below the 200-day average — consistent with a “death cross” (bearish) configuration.

30-day volatility43.0%
Average true range5.82% of price
Max drawdown (1y)-37.2%
Volume (10d vs 90d)1.94x

Discussion

No comments yet — be the first to weigh in on IMTX.

Leave a comment

Scroll to Top